aspaveli
swedish orphan biovitrum ab (publ) - pegcetacoplan - hemoglobinuria, paroxysmal - immunosuppressantit - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.
carvedilol hexal 3.125 mg tabletti
hexal a/s - carvedilol - tabletti - 3.125 mg - karvediloli
carvedilol hexal 6.25 mg tabletti
hexal a/s - carvedilol - tabletti - 6.25 mg - karvediloli
carvedilol hexal 12.5 mg tabletti
hexal a/s - carvedilol - tabletti - 12.5 mg - karvediloli
carvedilol hexal 25 mg tabletti
hexal a/s - carvedilol - tabletti - 25 mg - karvediloli
carvedilol hexal 50 mg tabletti
hexal a/s - carvedilol - tabletti - 50 mg - karvediloli
kandrozid 4 mg tabletti
viatris limited - candesartan cilexetil - tabletti - 4 mg - kandesartaani
kandrozid 8 mg tabletti
viatris limited - candesartan cilexetil - tabletti - 8 mg - kandesartaani
kandrozid 16 mg tabletti
viatris limited - candesartan cilexetil - tabletti - 16 mg - kandesartaani
kandrozid 32 mg tabletti
viatris limited - candesartan cilexetil - tabletti - 32 mg - kandesartaani